{"url_path":"/sec/ccrn/10-q/2026/item-5","section_key":"item-5","section_title":"Item 5 OTHER INFORMATION","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-08","source_url":"https://www.sec.gov/Archives/edgar/data/1141103/0001628280-26-032542-index.html","accession_number":"0001628280-26-032542","cik":"0001141103","ticker":"CCRN","issuer_name":"CROSS COUNTRY HEALTHCARE INC","edgar_url":"https://www.sec.gov/Archives/edgar/data/1141103/0001628280-26-032542-index.html","primary_entity_key":"0001141103","primary_entity_name":"CROSS COUNTRY HEALTHCARE INC"},"word_count":246,"has_tables":true,"body_markdown":"ITEM 5. OTHER INFORMATION\n\nAs previously disclosed in the Company’s Current Report on Form 8-K filed with the SEC on May 6, 2026, the Board has determined to cancel the Company’s 2026 Annual Meeting of Stockholders (2026 Annual Meeting), which was previously scheduled to be held virtually on May 11, 2026, and to withdraw from consideration by the Company’s stockholders the proposals set forth in the proxy statement for the 2026 Annual Meeting filed with the SEC on March 30, 2026, as revised by Amendment No. 1 thereto filed with the SEC on April 2, 2026.\n\n(c) Trading Plans\n\nCertain directors and officers (as defined in Rule 16a-1(f) under the Exchange Act) of the Company may execute purchases and sales of the Company’s common stock through Rule 10b5-1 and non-Rule 10b5-1 equity trading plans. Pursuant to Item 408(a) of Regulation S-K, we are required to disclose whether any director or officer adopted or terminated a Rule 10b5-1 trading\n\n32\n\narrangement or non-Rule 10b5-1 trading arrangement (as that term is defined in Item 408(c) of Regulation S-K) during the most recently completed quarter.\n\nDuring the three months ended March 31, 2026 neither the Company nor any of its Section 16 officers or directors adopted, modified, or terminated any contract, instruction, or written plan for the purchase or sale of the Company’s securities, under either a Rule 10b5-1 trading arrangement or a non-Rule 10b5-1 trading arrangement (in each case, as defined in Item 408(a) of Regulation S-K).\n\n33"}